期刊文献+

八味丸方药对代谢综合征患者治疗效应的临床观察 被引量:16

Clinical observation on the effect of Ba-Wei-Wan decoction in treating patients with metabolic syndrome
在线阅读 下载PDF
导出
摘要 目的:考察八味丸方药(汤剂)对代谢综合征患者血糖、血压、血脂、血胰岛素及血浆过氧化脂质等的影响。方法:将60例代谢综合征患者随机分为实验组和对照组,对照组服卡托普利和二甲双胍,实验组在此基础上加服八味丸方汤剂,疗程60天,观察两组治疗前后血糖、血压、血脂、血胰岛素及血浆过氧化脂质等指标变化。结果:实验组有效率明显高于对照组(p<0.01)。与对照组相比,实验组治疗后的血糖、血压、血脂、血胰岛素及血浆过氧化脂质等指标的改善更明显(p<0.05orp<0.01)。结论:本研究结果提示,八味丸方药对代谢综合征的降糖、降脂、降胰岛素和降压作用主要是通过改善IR而实现的;八味丸方药较好的改善IR及相关病理生理改变的作用,可能与其降低血浆过氧化脂质有关。 The primary purpose of this study was to assess the effectiveness of Ba-Wei-Wan decoction on hypertension, hyperglycemia,hypedipidimia and hyperinsulinemia in patients with metabolic syndrome. Methods: Sixty patients were randomized to the treatment or control group (each group contains 30 members). The treatment group received Capoprial and Metformin combined with Ba-Wei-Wan decoction and the control group received Capoprial and Metformin alone for 60 days. Blood pressure, the level of plasma glucose, TG, TC, HDL-c, insulin and LPO were measured at baseline and at study end. Results: Compared with the control group, the treatment group gained a better effective rate (90% vs 60%, p〈0.01). The treatment group also experienced a significantly greater reduction in blood pressure, and in the plasma glucose, TG, TC, insulin and LPO compared with the control group (p〈0.05, p(0.01). Conclusion: The results suggested that the effectiveness of Ba-Wei-Wan decoction on hyperglycemia, hyperlipidimia, hyperinsulinemia and hypertension in patients with Metabolic Syndrome is mainly due to the improvement of insulin resistance; the better effect of Ba-Wei-Wan decoction on insulin resistance and related disorders was considered to be partly due to a significant decrease in serum LPO.
作者 潘玲 冯全生
出处 《四川生理科学杂志》 2005年第2期78-82,共5页 Sichuan Journal of Physiological Sciences
关键词 胰岛素抵抗 代谢综合征 八味丸(八味地黄丸) 卡托普利 二甲双胍 衰老 过氧化脂质 八味丸 临床观察 治疗效应 Insulin resistsnce metabolic syndrome Ba-Wei-Wan Capoprial Metformin Aging LPO
作者简介 潘玲(1961.6.29),女,河北沧州人,医师,副高级工程师,博士,从事中西医结合临床,并从事中药新药及保健食品的研究开发。作者单位:610041四川省中医药研究院附属医院。E-mail:lingpan61@sima.com
  • 相关文献

参考文献12

二级参考文献8

共引文献2221

同被引文献218

引证文献16

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部